Cvs Health CORP Form 4 insider transactions

EVP and Chief Medical Officer of CVS Health, Sreekanth K. Chaguturu, reports acquisition and disposal of company stock and stock options.

Laurie Havanec, EVP and Chief People Officer at CVS Health, reports the acquisition and disposal of company stock and stock options.

EVP & President of Pharmacy Services at CVS Health, J. David Joyner, reports acquisition of restricted stock units and disposal of common stock.

EVP/President of Aetna, Brian A. Kane, reports the acquisition of restricted stock units and stock options in CVS Health Corp.

EVP, CPO and General Counsel of CVS Health, Samrat S. Khichi, reports acquisition of restricted stock units and stock options, along with disposal of common stock.

Thomas F. Cowhey, EVP and CFO of CVS Health, reports acquisition and disposal of CVS common stock and stock options.

Prem S. Shah, EVP and President of Pharmacy and Consumer Wellness at CVS Health, reports the acquisition and disposal of company stock and derivative securities.

EVP and Chief Technology Officer of CVS Health, Tilak Mandadi, reports acquisition of restricted stock units and stock options, as well as disposal of common stock.

Karen Lynch, President and CEO of CVS Health, reports acquisition of restricted stock units and stock options, as well as disposition of shares for tax obligations.

J. David Joyner, EVP & President of Pharmacy Services at CVS Health, reported a transaction involving the surrender of shares to cover withholding taxes upon vesting of a restricted stock award on February 28, 2024.

Thomas F. Cowhey, SVP and Interim CFO of CVS Health Corp, reports changes in beneficial ownership of common stock due to the vesting of a restricted stock award and associated tax obligations.

EVP, CPO and General Counsel of CVS Health, Samrat S. Khichi, reports the surrender of shares to cover withholding taxes upon vesting of a restricted stock award.

Prem S. Shah, EVP and President of Pharmacy and Consumer Wellness at CVS Health, reported the disposition of 261 shares of common stock to cover withholding taxes upon vesting of a restricted stock award on February 26, 2024.

EVP and Chief Medical Officer of CVS Health, Sreekanth K. Chaguturu, reports the surrender of shares to cover withholding taxes upon vesting of a restricted stock award.

Laurie P. Havanec, EVP and Chief People Officer of CVS Health Corp, reported the surrender of 6,698 shares of common stock to cover withholding taxes upon the vesting of a restricted stock award on February 26, 2024.